cancer

Health By Meghana Keshavan

Study offers new clues for treating brain cancer in children

Heavyweights By Eric Boodman

As a kid, his factory work paid for his dad’s cancer care. As an oncologist, his research offers more than survival

First Opinion By Linda S. Birnbaum and Margaret L. Kripke

The National Cancer Institute needs to publish information about chemical exposure and cancer risk

In the Lab By Elizabeth Cooney

Cancer vaccine cocktail boosts immune response after melanoma surgery, research shows

First Opinion By Jessica Stuart

I was a ‘nonadherent’ patient. That’s made me a more empathetic doctor

Health By Priyanka Runwal

After a breast cancer diagnosis, many Black women face barriers that delay their care

In the Lab By Elizabeth Cooney

Training the innate immune system to thwart cancer could open door to a new therapy

Health Tech By Casey Ross

Google and the Mayo Clinic to use AI to better target radiation therapy

Health By Nicholas St. Fleur

Colorectal cancer screening should start five years earlier — at 45 — expert panel says

Biotech By Kate Sheridan

Exact Sciences acquires liquid biopsy company Thrive for $2.15 billion

Biotech By Adam Feuerstein

Mirati study results set new response bar for KRAS-blocking lung cancer drugs

Pharma By Rebecca Ritzel

FDA pushes drug companies to include younger people in breast cancer drug trials 

First Opinion By Zachary A.K. Frosch, Lawrence N. Shulman, and Justin E. Bekelman

3 ways to counter Covid-19’s threat to community-based cancer care

Biotech By Adam Feuerstein

CRISPR Therapeutics’ CAR-T treatment shows encouraging results, but one death is tied to therapy

Biotech By Jonathan Chan

A conversation with Exuma Biotech’s CEO about CAR-T and China’s strategic advantages

First Opinion By Charlotte Grinberg

It should be easy for people to receive end-of-life care at home. Why is it so hard?

Health By Alexander Spinelli

‘We have to deal with uncertainty’: FDA leaders explain how Covid-19 has upended cancer research and care

Biotech By Adam Feuerstein

The biotech scorecard for the fourth quarter: 18 stock-moving events to watch

Biotech By Damian Garde

With a new CEO, a small biotech is out to prove Wall Street wrong

Health By Pratibha Gopalakrishna

New research shows older adults are still often excluded from clinical trials

Biotech By Matthew Herper

‘The largest application we can imagine’: Illumina and Grail CEOs defend their deal to investors

Video Chat By Adam Feuerstein

STAT Virtual Event: The ESMO Recap, Live!

Health Tech By Rebecca Robbins

When AI is the opposite of sinister: An MIT researcher is held up as model of how algorithms can benefit humanity

First Opinion By Steven Petrow

Cancer survivor: Don’t forget that accolade when it comes to Ruth Bader Ginsburg’s remarkable life

Biotech By Adam Feuerstein

Coming for the king: Keytruda dominates the immunotherapy market, but challengers are lining up